Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness

Ann Rheum Dis. 2024 Nov 14;83(12):1796-1797. doi: 10.1136/ard-2024-225912.

Cecilia Leijding¹, Suchada Kaewin¹, Kristofer M Andreasson^{2

3}, Begum Horuluoglu^{2

4

5}, Angeles Shunashy Galindo-Feria^{2

4

5}, Eveline Van Gompel^{2

4

5}, Maryam Dastmalchi^{2

4

5}, Stefano Gastaldello¹, Helene Alexanderson^{2

3

4}, Ingrid E Lundberg^{2

4

5}, Daniel C Andersson^{6

7}

¹ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
² Department of Medicine, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
³ Women's Health and Allied Health Professionals Theme, Medical Unit Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden.
⁴ Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Gastro, Dermatology and Rheumatology,Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden daniel.c.andersson@ki.se.
⁷ Unit for Cardiology, Heart, Vascular and Neurology Theme, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Keywords: Autoantibodies; Autoimmune Diseases; Dermatomyositis; Inflammation; Polymyositis.

Publication types